TY - JOUR
T1 - Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients
AU - Li, Yangkai
AU - Liu, Zhensheng
AU - Liu, Hongliang
AU - Wang, Li E.
AU - Onodera, Hisashi
AU - Suzuki, Akihiro
AU - Suzuki, Koyu
AU - Wadhwa, Roopma
AU - Elimova, Elena
AU - Sudo, Kazuki
AU - Shiozaki, Hironari
AU - Estrella, Jeannelyn
AU - Lee, Ju Seog
AU - Song, Shumei
AU - Tan, Dongfeng
AU - Ajani, Jaffer A.
AU - Wei, Qingyi
PY - 2014/9
Y1 - 2014/9
N2 - Functional genetic variants of DNA repair genes may alter the host DNA repair capacity, and thus influence efficiency of therapies. We genotyped eight potentially functional single nucleotide polymorphisms (SNPs) in genes (i.e. ERCC1, XPA, XPC, XPD and XPG) involved in the nucleotide excision repair (NER) pathway in 496 Japanese gastric cancer patients, and assessed overall survival and recurrence-free survival. The combined effects of risk genotypes of these eight SNPs in Japanese patients were further replicated in 356 North-American gastric cancer patients. In Japanese patients, we found that the XPC rs2228000 TT genotype was associated with shorter overall survival [hazards ratio (HR) = 1.75, 95% confidence interval (95% CI) = 1.07-2.86] and recurrence-free survival (HR = 2.17, 95% CI = 1.19-3.95), compared with CC/CT genotypes, and the XPG rs17655 CC genotype was associated with shorter overall survival (HR = 1.60, 95% CI = 1.08-2.36), compared with GG/CG genotypes. The number of observed risk genotypes in the combined analysis was associated with shorter overall survival and recurrence-free survival in a dose-response manner (Ptrend = 0.006 and Ptrend < 0.000) in Japanese patients; specifically, compared with those with ≤1 risk genotypes, those with ≥2 risk genotypes showed markedly shorter overall survival (HR = 1.79, 95% CI = 1.18-2.70) and recurrencefree survival (HR = 2.80, 95% CI = 1.66-4.73). The association between ≥2 risk genotypes and shorter overall survival was not significant (HR = 1.26, 95% CI = 0.82-1.94) in North-American patients, but the trends were similar in these two groups of patients. These data show that functional SNPs in NER core genes may impact survival in Japanese gastric cancer patients.
AB - Functional genetic variants of DNA repair genes may alter the host DNA repair capacity, and thus influence efficiency of therapies. We genotyped eight potentially functional single nucleotide polymorphisms (SNPs) in genes (i.e. ERCC1, XPA, XPC, XPD and XPG) involved in the nucleotide excision repair (NER) pathway in 496 Japanese gastric cancer patients, and assessed overall survival and recurrence-free survival. The combined effects of risk genotypes of these eight SNPs in Japanese patients were further replicated in 356 North-American gastric cancer patients. In Japanese patients, we found that the XPC rs2228000 TT genotype was associated with shorter overall survival [hazards ratio (HR) = 1.75, 95% confidence interval (95% CI) = 1.07-2.86] and recurrence-free survival (HR = 2.17, 95% CI = 1.19-3.95), compared with CC/CT genotypes, and the XPG rs17655 CC genotype was associated with shorter overall survival (HR = 1.60, 95% CI = 1.08-2.36), compared with GG/CG genotypes. The number of observed risk genotypes in the combined analysis was associated with shorter overall survival and recurrence-free survival in a dose-response manner (Ptrend = 0.006 and Ptrend < 0.000) in Japanese patients; specifically, compared with those with ≤1 risk genotypes, those with ≥2 risk genotypes showed markedly shorter overall survival (HR = 1.79, 95% CI = 1.18-2.70) and recurrencefree survival (HR = 2.80, 95% CI = 1.66-4.73). The association between ≥2 risk genotypes and shorter overall survival was not significant (HR = 1.26, 95% CI = 0.82-1.94) in North-American patients, but the trends were similar in these two groups of patients. These data show that functional SNPs in NER core genes may impact survival in Japanese gastric cancer patients.
UR - http://www.scopus.com/inward/record.url?scp=84906825839&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84906825839&partnerID=8YFLogxK
U2 - 10.1093/carcin/bgu142
DO - 10.1093/carcin/bgu142
M3 - Article
C2 - 24990617
AN - SCOPUS:84906825839
SN - 0143-3334
VL - 35
SP - 2031
EP - 2038
JO - Carcinogenesis
JF - Carcinogenesis
IS - 9
M1 - Article bgu142
ER -